Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MMPP is a novel VEGFR2 inhibitor with anti-inflammatory and potential anticancer activity, inhibits STAT3, inhibits angiogenesis via VEGFR2/AKT/ERK/NF-kappaB pathway, and can be used to alleviate myocardial injury.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 257.00 | |
5 mg | In stock | $ 638.00 | |
10 mg | In stock | $ 912.00 | |
25 mg | In stock | $ 1,370.00 | |
50 mg | In stock | $ 1,850.00 |
Description | MMPP is a novel VEGFR2 inhibitor with anti-inflammatory and potential anticancer activity, inhibits STAT3, inhibits angiogenesis via VEGFR2/AKT/ERK/NF-kappaB pathway, and can be used to alleviate myocardial injury. |
Molecular Weight | 270.32 |
Formula | C17H18O3 |
CAS No. | 1895957-18-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 27.03 mg/mL (100 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MMPP 1895957-18-2 Angiogenesis JAK/STAT signaling Stem Cells Tyrosine Kinase/Adaptors STAT VEGFR inhibitor inhibit